Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?

× No keyword cloud information.

10 in total

1. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Authors: Sebastian Nuding; Henning Ebelt; Robert S Hoke; Annette Krummenerl; Andreas Wienke; Ursula Müller-Werdan; Karl Werdan
Journal: Clin Res Cardiol Date: 2011-06-03 Impact factor: 5.460

2. Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.

Authors: Michele Correale; Deodata Montrone; Matteo Di Biase; Natale Daniele Brunetti
Journal: Clin Res Cardiol Date: 2012-03-02 Impact factor: 5.460

3. Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery.

Authors: Domenico Vitale; Vincenzo De Santis; Fabio Guarracino; Andrea Fontana; Fabio Pellegrini; Luigi Tritapepe
Journal: Clin Res Cardiol Date: 2010-09-07 Impact factor: 5.460

4. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral.

Authors: Roberto Badagliacca; Beatrice Pezzuto; Roberto Poscia; Massimo Mancone; Silvia Papa; Serena Marcon; Gabriele Valli; Gennaro Sardella; Fabio Ferrante; Carlo Iacoboni; Daniela Parola; Francesco Fedele; Carmine Dario Vizza
Journal: J Heart Lung Transplant Date: 2012-01-29 Impact factor: 10.247

5. Ivabradine in systemic sclerosis related pulmonary arterial hypertension.

Authors: Michele Correale; Deodata Montrone; Riccardo Ieva; Matteo Di Biase; Natale Daniele Brunetti
Journal: Eur J Intern Med Date: 2012-09-26 Impact factor: 4.487

6. Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.

Authors: Ruoyu Zhang; Dmitry Bobylev; Penelope Stiefel; Axel Haverich; Christoph Bara
Journal: Clin Res Cardiol Date: 2012-03-04 Impact factor: 5.460

7. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.

Authors: Frances S de Man; M Louis Handoko; Joris J M van Ballegoij; Ingrid Schalij; Sylvia J P Bogaards; Pieter E Postmus; Jolanda van der Velden; Nico Westerhof; Walter J Paulus; Anton Vonk-Noordegraaf
Journal: Circ Heart Fail Date: 2011-12-09 Impact factor: 8.790

Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?